Shuttle Pharmaceuticals Holdings, Inc. SHPH
4.01
0.01
0.25%
as of 25 Sep
- Market cap
- $15.6M
- P/E
- 34.7×
Follow SHPH
Insider Buys
alert about insiders buying in the last 12 month
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
0.30 | 0.06 | 1.66 | 3.07 |
+8 more quarters Free account |
Net Debt/EBITDA |
0.69 | 0.13 | 0.93 | 1.24 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.12 | 0.37 | 1.12 | 0.91 | |
Capex/Depreciation |
(0.06) | (10.09) | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.78 | 0.94 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(4.88) | (24.60) | (11.76) | (29.80) | |
Cash per Share |
2.17 | 2.04 | 9.38 | 42.79 | |
Shareholders Equity per Share |
6.65 | 13.76 | 6.24 | 32.02 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.65 | 13.76 | 6.24 | 32.02 | |
Free Cash Flow |
(2.45) | (4.03) | (2.63) | (3.36) | |
Working Capital |
(5.84) | (7.46) | 1.30 | 3.50 | |
Capital Expenditures |
(0.04) | (3.06) | — | — | |
Net Current Asset Value |
(6.00) | (7.72) | 1.12 | 3.29 | |
| Other line items | |||||
Quick Ratio |
0.13 | 0.04 | 1.07 | 2.85 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.80) | (5.94) | (11.76) | (29.80) | |
Capex per Share |
(0.07) | (18.66) | 0.00 | 0.00 | |
Average Payables |
1.34 | 1.03 | 1.41 | 0.77 | |
Average Assets |
8.56 | 6.49 | 2.11 | 4.16 | |
Average Common Equity |
3.32 | 1.48 | 0.04 | 2.20 | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates